PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
 
Send Us Some Feedback
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
September 18, 2014 | ISSUE NUMBER 369 VOL 4

World Health
Ebola Crisis Could Spur Broader R&D Efforts
While public and private organizations are rising to the challenge of developing treatments to subdue Ebola, the world is watching to see if these efforts translate into broader R&D on drugs and preventives for other neglected tropical diseases (NTDs). Jill Wechsler reports ...Read more

Global
Scottish Independence: UK Life Sciences Sector Voices Concerns
Experts, politicians and other interested parties in both London and Scotland have spoken out of their concerns for life sciences R&D in Scotland should the ‘Yes-to-independence’ vote prevail in today’s historic UK referendum ...Read more

Inspection Focus in Clinical Trials Using a Risk-Based Monitoring Approach
How will clinical trials that adopt an RBM approach be inspected? Covance shares actionable insights to start answering this vitally important question. Learn more

Global
The Future of Pharma in Ireland
A panel of local leaders from industry, government, and the CRO community convened for a Pharm Exec roundtable to examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the world’s leading exporter of finished pharmaceutical products ...Read more

Cut Sampling Costs by 30%
Total sample management outsourcing can will not only save you time and money but help to strengthen your compliance.  But you need to know who you are trusting with your samples – and your compliance.  Discover some tips for choosing a third party compliance vendor and learn how an efficient program can help cut your sample distribution costs by up to 30%.

Emerging Markets
Healthcare Reform in China: Double-Edged Sword for Foreign Firms?
The Chinese market is the world’s third largest market for pharmaceuticals with annual sale of US$71 billion and it is poised to become the second largest market in 2015. But the country’s healthcare reforms may be a double-edged sword for foreign companies looking to invest, writes Jane Wan ...Read more

Engineer Your Business to Win in the Mobile Selling Moment
Live Webinar: Thursday, September 25, 2014 12pm ET

Smartphones and tablets are becoming an extension of our brains. When we don’t immediately find what we want, we turn to our phone or tablet and look for a service to help. This is just as true for healthcare providers (HCPs) and employees as for consumers. In this webcast, you’ll learn to identify the mobile moments critical to engaging HCPs.
Register Free at www.pharmexec.com/mobileselling

Events
Latest Developments in Alzheimer’s R&D
With drug-development efforts in Alzheimer’s disease continuing to produce underwhelming results, it’s no secret that there is increased clinical focus now on its prevention and early detection. Those were two areas of emphasis at the recent Alzheimer’s Association International Conference (AAIC) in Denmark. Michael Christel reports on the event’s highlights ...Read more

//Elan Z. Ezickson has joined biotech start-up Scholar Rock (Cambridge, MA) as Chief Operating Officer and Head of Corporate Development.//AMAG Pharmaceuticals (Waltham, MA) announced that Judith Johnson, M.D., has rejoined the company as Vice President of Pharmacovigilance and Pharmacoepidemiology.//Purdue Pharma (Stamford, CT) announced that Susie Robinson, formerly of Lumeris, has joined the company as Vice President of Human Resources.//Agilis Biotherapeutics (New York, NY) named Dr. Mark Pykett as President and CEO.//

October 21–22: International Pharmaceutical Compliance Congress
Brussels, Belgium.


November 5–6: Real World Data/Late Phase Summit
Philadelphia, Pennsylvania


Jan 29–30, 2015: 10th Annual Summit on Biosimilars
Washington, DC



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

Survey
Which of these countries do you believe will drive most of pharma's growth over the next 12 months?

Click To Vote

Quick Links

Alfred Hitchcock: OTC Drug Salesman

The Pharm Exec Annual Industry Audit

Executive Coaching: Transforming Big Pharma from Within

European Pharma Paying the Price of Pharmacovigilance

Pharm Exec eBooks Available as Apps